Agios Provides Business Update on Discovery Research Strategy and Pipeline, Progress on Clinical Programs, Commercial Launch Preparations and Reports First Quarter 2018 Financial Results at Investor D
Go back to Agios Provides Business Update on Discovery Research Strategy and Pipeline, Progress on Clinical Programs, Commercial Launch Preparations and Reports First Quarter 2018 Financial Results at Investor D| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 33.95 +0.88 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.07 | 52 Week High | $71.49 | |||
| Open | $33.70 | 52 Week Low | $33.50 | |||
| Day High | $34.14 | P/E | N/A | |||
| Day Low | $33.30 | EPS | $-1.18 | |||
| Volume | 884,551 | |||||
